Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2 by Driouich, J-S, Cochin, M, Touret, F, Petit, P-R, Gilles, M, Moureau, G, Barthélémy, K, Laprie, C, Wattanakul, T, Chotsiri, P, Hoglund, RM, Tarning, J, Fraisse, L, Sjö, P, Mowbray, CE, Escudié, F, Scandale, I, Chatelain, E, de Lamballerie, X, Solas, C, Nougairède, A

Structure and functionality in flavivirus NS-proteins: perspectives for drug design. by Bollati, M, Alvarez, K, Assenberg, R, Baronti, C, Canard, B, Cook, S, Coutard, B, Decroly, E, de Lamballerie, X, Gould, E, Grard, G, Grimes, J, Hilgenfeld, R, Jansson, A, Malet, H, Mancini, E, Mastrangelo, E, Mattevi, A, Milani, M, Moureau, G, Neyts, J, Owens, R, Ren, J, Selisko, B, Speroni, S

Need for a standardized translational drug development platform: lessons learned from the repurposing of drugs for COVID-19 by Assmus, F, Driouich, J-S, Abdelnabi, R, Vangeel, L, Touret, F, Adehin, A, Chotsiri, P, Cochin, M, Foo, CS, Jochmans, D, Kim, S, Luciani, L, Moureau, G, Park, S, Pétit, P-R, Shum, D, Wattanakul, T, Weynand, B, Fraisse, L, Ioset, J-R, Mowbray, CE, Owen, A, Hoglund, RM, Tarning, J, Lamballerie, XD, Nougairède, A, Neyts, J, Sjö, P, Escudié, F, Scandale, I, Chatelain, E